Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.131
+0.005 (3.97%)
Nov 20, 2024, 4:00 PM EST - Market closed
Zomedica Employees
Zomedica had 144 employees as of December 31, 2023. The number of employees increased by 59 or 69.41% compared to the previous year.
Employees
144
Change (1Y)
59
Growth (1Y)
69.41%
Revenue / Employee
$185,604
Profits / Employee
-$431,903
Market Cap
128.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Protalix BioTherapeutics | 208 |
Cibus | 183 |
Repare Therapeutics | 179 |
Compugen | 68 |
Elutia | 54 |
Candel Therapeutics | 42 |
Outlook Therapeutics | 24 |
Context Therapeutics | 5 |
ZOM News
- 7 days ago - Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - Accesswire
- 9 days ago - Noble Capital Markets Initiates Equity Research Coverage on Zomedica - Accesswire
- 13 days ago - Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Accesswire
- 13 days ago - Zomedica Corp. (ZOM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - Accesswire
- 4 weeks ago - Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - Accesswire
- 4 weeks ago - Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - Accesswire
- 5 weeks ago - Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference - Accesswire